Anthony Petrosini, MD
Sports Medicine · Manasquan, NJNPI 1962481499
Payments from drug & device makers
What this record shows
Zimmer Biomet accounts for 66.7% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2024 at $1,841 and has fallen 92.2% since, to $144 in 2025.
Across 50 payments — averaging $52.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$2K
- Johnson & Johnson$341
- Bioventus LLC$95
- Stryker$84
- Medshape, Inc.$82
- Ferring Pharmaceuticals Inc.$74
- plus $204 from 10 others
Across 13 payments — averaging $5769.23 each. An ownership or investment interest held by the physician or an immediate family member.
- Centinel Spine, LLC$75K
What the payments were for
- Travel & lodging$1,34851%
- Food & beverage$1,29049%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 13 | $1,759 |
| Johnson & Johnson | 14 | $341 |
| Bioventus LLC | 4 | $95 |
| Stryker | 2 | $84 |
| Medshape, Inc. | 1 | $82 |
| Ferring Pharmaceuticals Inc. | 5 | $74 |
| Treace Medical Concepts, Inc. | 1 | $43 |
| Sanofi-aventis U.S. LLC | 2 | $30 |
| Biotronik NRO, Inc. | 1 | $25 |
| DJO, LLC | 1 | $18 |
| Nevro Corp. | 1 | $18 |
| Pacira Therapeutics, Inc. | 1 | $15 |
| Orthogenrx Inc. | 1 | $15 |
| Baxter Healthcare | 1 | $14 |
| Smith+Nephew | 1 | $13 |
| Integrity Implants Inc. Dba Accelus | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,638 in reported general payments places this provider in the 65th percentile of 221 sports medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Naproxen | 43 | $170 |
| Methylprednisolone | 18 | $108 |
| Meloxicam | 14 | $53 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Manasquan
- Sean McMillanBurlington$1.8M
- Nicholas JarmonFreehold$277K
- Thomas YoumEnglewood$221K
- Stephen HuntCedar Knolls$76K
- David PorterHackensack$63K
- Francis AlbertaHackensack$61K
- Nathan HolmesSewell$56K
- Steven FreyWoodbury$55K
- Lon CastleFranklin Lakes$54K
- Dante MarconiSomers Point$49K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.